2016

Winchester, Catherine and Salji, Mark ORCID: https://orcid.org/0000-0003-4261-3086 (2016) Writing a literature review. Journal of Clinical Urology, 9(5), pp. 308-312. (doi: 10.1177/2051415816650133)

2015

Dawson, N. et al. (2015) Altered functional brain network connectivity and glutamate system function in transgenic mice expressing truncated Disrupted-in-Schizophrenia 1. Translational Psychiatry, 5(5), e569. (doi: 10.1038/tp.2015.60) (PMID:25989143)

2014

Winchester, Catherine L., Pratt, Judith A. and Morris, Brian J. ORCID: https://orcid.org/0000-0003-4439-0795 (2014) Risk genes for schizophrenia: translational opportunities for drug discovery. Pharmacology and Therapeutics, 143(1), pp. 34-50. (doi: 10.1016/j.pharmthera.2014.02.003)

2012

Winchester, C.L., Ohzeki, H., Vouyiouklis, D.A., Thompson, R., Penninger, J.M., Yamagami, K., Norrie, J.D., Hunter, R., Pratt, J.A. and Morris, B.J. ORCID: https://orcid.org/0000-0003-4439-0795 (2012) Converging evidence that sequence variations in the novel candidate gene MAP2K7 (MKK7) are functionally associated with schizophrenia. Human Molecular Genetics, 21(22), pp. 4910-4921. (doi: 10.1093/hmg/dds331)

2001

Winchester, Catherine and Wilson, J.B. ORCID: https://orcid.org/0000-0003-4715-2530 (2001) Mouse Models of CASK Disruption. Human Genome Meeting, Edinburgh, UK, 14 Apr 2001.

2000

Gonzalez, I. et al. (2000) New nomenclature and DNA testing guidelines for myotonic dystrophy type 1(DM1). Neurology, 54(6), 1218 -1221.

Articles

Winchester, Catherine and Salji, Mark ORCID: https://orcid.org/0000-0003-4261-3086 (2016) Writing a literature review. Journal of Clinical Urology, 9(5), pp. 308-312. (doi: 10.1177/2051415816650133)

Dawson, N. et al. (2015) Altered functional brain network connectivity and glutamate system function in transgenic mice expressing truncated Disrupted-in-Schizophrenia 1. Translational Psychiatry, 5(5), e569. (doi: 10.1038/tp.2015.60) (PMID:25989143)

Winchester, Catherine L., Pratt, Judith A. and Morris, Brian J. ORCID: https://orcid.org/0000-0003-4439-0795 (2014) Risk genes for schizophrenia: translational opportunities for drug discovery. Pharmacology and Therapeutics, 143(1), pp. 34-50. (doi: 10.1016/j.pharmthera.2014.02.003)

Winchester, C.L., Ohzeki, H., Vouyiouklis, D.A., Thompson, R., Penninger, J.M., Yamagami, K., Norrie, J.D., Hunter, R., Pratt, J.A. and Morris, B.J. ORCID: https://orcid.org/0000-0003-4439-0795 (2012) Converging evidence that sequence variations in the novel candidate gene MAP2K7 (MKK7) are functionally associated with schizophrenia. Human Molecular Genetics, 21(22), pp. 4910-4921. (doi: 10.1093/hmg/dds331)

Gonzalez, I. et al. (2000) New nomenclature and DNA testing guidelines for myotonic dystrophy type 1(DM1). Neurology, 54(6), 1218 -1221.

Conference or Workshop Item

Winchester, Catherine and Wilson, J.B. ORCID: https://orcid.org/0000-0003-4715-2530 (2001) Mouse Models of CASK Disruption. Human Genome Meeting, Edinburgh, UK, 14 Apr 2001.